Skip to main content

Author: Johnny Green

A Very Big Company Just Jumped Into Canada’s Cannabis Industry

News broke last week that Uber Technologies Inc is teaming up with Canadian cannabis retailer Tokyo Smoke.

The news was first reported by Reuters and initial reports misstated that Uber would allow cannabis to be ordered through the Uber app and delivered.

However, that initial reporting was later updated to reflect that orders can be placed through the app, although, customers will still need to obtain their cannabis the old-fashioned way.

Still, even Uber’s limited entry into the cannabis space is a big deal given how large the company is and that it previously had no known ties to the cannabis industry.

Part A Larger Trend

Uber Technologies Inc is not the first large company to enter the cannabis space. It is part of the continued mainstreaming of the legal cannabis industry.

As the emerging legal cannabis industry continues to evolve, and more notably continues to generate enormous revenue, there will be a steady flow of large companies entering the space.

That could be bad news for operators in entire sectors of the cannabis industry that have benefitted from big technology companies shying away from cannabis due to stigma and continued prohibition in some areas.

Cannabis delivery services are very popular in some areas because they fill a void. Once the Ubers of the world start performing that same service, it will obviously be much harder for smaller delivery companies to compete.

The same will be true for many technological concepts that are currently operating in the cannabis space.

Finding A Niche

Cannabis entrepreneurs that provide certain services still have time to establish themselves with consumers and patients before most of the big companies enter the space.

Now is the time for those companies to build their brand recognition and prove to consumers that they can provide just as good (or better) of service as big companies.

People that think they have a good idea in the current industry climate need to focus on their long-term plans in addition to their immediate plans.

Otherwise, a really big fish could enter the fold and if the person/company didn’t plan for that happening, it could be the difference between them continuing on or getting pushed out of the industry entirely.

Many Employers Are Dropping Cannabis Drug Testing Requirements To Attract Workers

Cannabis consumers come in all shapes, sizes, and backgrounds. Despite what mainstream media would have you believe over the course of many decades, all walks of life consume cannabis.

Consumers have faced all types of discrimination because of prohibition, with one particularly difficult form of discrimination occurring in the labor market.

As many cannabis consumers will attest, they either refrained from applying for a job, were prevented from being hired, or were later terminated because of failing a drug test for cannabis.

Workers should be measured by their skills, morals, and contributions to a workplace, and not by the presence of metabolized THC in their bodily fluids. Fortunately, more and more employers are ditching cannabis drug testing. Below is more information about it via a news release from our friends at NORML:

Some employers are abandoning drug testing requirements as a way to attract new hires and to retain current employees, according to survey data compiled by the Manpower Group.

Pollsters surveyed representatives from over 45,000 employers in North America and Europe. Nine percent of respondents acknowledged that they had “eliminated job screenings or drug tests” as a way to either attract or keep their employees. Sixty-nine percent of respondents acknowledged experiencing “difficulty” in filling staffing positions in the current job market, a 15-year high.

In June, representatives of the Amazon corporation announced that the company would no longer engage in pre-employment marijuana screenings for its new hires, except for those in federally regulated positions (that mandate drug testing). The company further announced in September that it had “reinstated eligibility for former employees and applicants who were previously terminated or deferred during random or pre-employment marijuana screenings.” The Amazon corporation is the second-largest employer in the United States.

In recent months, lawmakers in several states - Nevada, New Jersey, New York, and Montana - have enacted policies limiting employers’ ability to pre-screen applicants for past marijuana use, as have councilmembers in a growing number of municipalities, including AtlantaPhiladelphia, and Washington, DC. New York’s policy further limits employers’ ability to sanction current employees for their off-hours marijuana use absent evidence of “articulable symptoms of cannabis impairment.”

Urinalysis detects the presence of inactive marijuana byproducts that may be present for as many as 100 days post-abstinence. As per the United States Department of Justice, the detection of these products “only indicates that a particular substance is present in the test subject’s body tissue. It does not indicate abuse or addiction; recency, frequency, or amount of use; or impairment.” Additional information is available from NORML’s fact sheet, ‘Marijuana Legalization and Impact on the Workplace.’

Writing About Cannabis Is A Crime In Czech Republic

In early October we reported on a disturbing situation in the Czech Republic regarding a cannabis media company and its editor being persecuted by the government for doing nothing more than providing cannabis education. Unfortunately, the case resulted in a conviction, which is inhumane, to say the least.

It sets a dangerous precedent for the repression of freedom of speech and people’s right to information. If you care about freedom of the press, you are encouraged to donate to Robert Veverka’s crowdfunding transparent bank account no. 2900469065/2010
(IBAN: CZ4320100000002900469065, BIC/SWIFT: FIOBCZPPXXX - https://ib.fio.cz/ib/transparent?a=2900469065). The funds collected will be used to cover the costs of the lawsuit and for the further fight for freedom of expression. Below is more information about the case via a press release sent out by Magazin Legalizace:

On November 3, 2021, the Legalizace magazine and its editor-in-chief, Robert Veverka, were convicted of inciting and promoting “toxicomania” by the district court in the town of Bruntál.

The editor-in-chief, Robert Veverka, and the publishing company of the Legalizace magazine, both prosecuted since the summer of 2020 for allegedly inciting and promoting “toxicomania”, were given a one-year prison sentence contingent on a probationary period of two and a half years as well as a fine of 50,000 CZK by the district court in Bruntál following two court hearings.

According to the public prosecutor, Jan Žalman, Veverka and the publishing company have committed the crime of inciting and promoting toxicomania by publishing more than two hundred articles during 2010-2020 which allegedly gave the impression of cannabis processing and handling being legal, provided qualified instructions on cannabis cultivation, processing, and storage, and by publishing cannabis-themed advertisements as well as offering legal and freely marketable cannabis seeds which appeared several times as a supplement of the printed magazine issues. This conjecture was confirmed by Judge Marek Stach in his verdict on November 3, 2021, when he found the defendants guilty of the above.

Although the judge admitted that the Legalizace magazine gives the impression of a very objective medium, as it provides broadscale, comprehensive information and expert opinions as well as insight into the medical aspects of cannabis, he proclaimed the reason for his verdict is that some of the articles may incite the desire in certain individuals to acquire equipment that could enable them to grow, harvest, process, and use cannabis in a way which is illegal. The judge also stated that if the printed photographs depict cannabis flowers evidently covered with resin, these images cannot therefore be of industrial cannabis without psychoactive properties. According to the judge, such content is a temptation to readers; almost every issue of the magazine allegedly possesses the capability of influencing the conduct of readers and inciting them to abuse addictive substances. Although the majority of the articles found in the published magazine issues are legally sound, according to Judge Marek Stach, even one single article with the potential to incite readers is enough for the Legalizace magazine to constitute the crime of inciting and promoting toxicomania.

“The judge mentioned that he is not competent to assess the benefits of the current legislation, the benefits of cannabis products in healthcare, or the negative effects of cannabis use, but that he must base his verdict on the existing legislation which is binding for all. He stated that according to his judgement, Legalizace magazine evidently and factually constituted the criminal offence of inciting and promoting toxicomania. He did not take into account the legislative provisions allowing for cannabis to be handled legally in certain cases or the comprehensive and educational nature of the information published in the magazine. On the contrary, the judge expressed his doubts as to whether the individuals who granted interviews to the magazine were made aware of its content and overall message. Personally, I consider the verdict to be very biased and severely restrictive of the freedom of expression, the right to express political opinion, and the right to information,” says Robert Veverka.

The verdict is not final, the defendants are waiting for the written statement of the reasons for the court’s decision to be issued and will use this time to consider a possible appeal. The verdict has caused considerable outrage among the lay and expert public alike, which is calling on the newly appointed Chamber of Deputies to update the outdated legislation on psychoactive substances and the specific section of the law referring to the inciting and promoting of toxicomania.

If you care about freedom of the press, you are encouraged to donate to Robert Veverka’s crowdfunding transparent bank account no. 2900469065/2010 (IBAN: CZ4320100000002900469065, BIC/SWIFT: FIOBCZPPXXX – https://ib.fio.cz/ib/transparent?a=2900469065). The funds collected will be used to cover the costs of the lawsuit and for the further fight for freedom of expression.

Media Contact:

Robert Veverka, tel. +420 773 691 561, email: robert@legalpub.cz

Website: https://magazin-legalizace.cz/, FB: https://www.facebook.com/magazinlegalizace

Robert Veverka is the publisher and editor-in-chief of Legalizace magazine, the head of the Legalizace.cz NGO, a member of the Prague Council Commission for Drug Policy Coordination, and a representative and member of the Security Commission and Education Commission of the Prague 2 municipal borough.

Why Looming Cannabis Legalization In Germany Is A Very Big Deal

News broke today that an agreement has been struck in Germany to legalize cannabis for adult use and to create a regulated adult-use cannabis industry framework.

Momentum for adult-use legalization in Germany was picking up steam leading up to the last election, which was discussed at length at our last conference in Berlin where we hosted <a href=”https://www.youtube.com/watch?v=8dg-SYV6WmE&amp;t=18s”target=”_blank”>a historic bipartisan discussion about cannabis policy in Germany</a> featuring panelists representing all major political parties in Germany.

Members of the incoming governing coalition comprised of the Social Democratic Party of Germany (SPD), the Free Democratic Party (FDP), and the Greens are reportedly introducing the measure in the upcoming session. Per&#160;<a href=”https://www.spiegel.de/politik/deutschland/ampel-parteien-einigen-sich-auf-legalisierung-von-cannabis-a-216b328b-5746-4eb8-afe6-034ea7a05269″target=”_blank”><em>Spiegel</em></a> (translated from German):
<blockquote><span>According to SPIEGEL information, the traffic light parties want&#160;to legalize&#160;the sale of&#160;</span><a href=”https://www.spiegel.de/thema/cannabis/” data-link-flag=”spon”><span>cannabis</span></a><span>&#160;for consumption purposes.&#160;The coalition working group on health and care agreed on this, as the Funke media group first reported.&#160;”We are introducing the controlled distribution of cannabis to adults for pleasure purposes in licensed shops,”&#160;stated&#160;the negotiators of the&#160;</span><a href=”https://www.spiegel.de/thema/spd/” data-link-flag=”spon”><span>SPD</span></a><span>&#160;, Greens and&#160;</span><a href=”https://www.spiegel.de/thema/fdp/” data-link-flag=”spon”><span>FDP</span></a><span>&#160;in the result paper of the relevant working group.&#160;This controls the quality, prevents the transfer of contaminated substances and guarantees the protection of minors.</span>

<span>According to the report, the relevant law is to be evaluated after four years with a view to its social impact.&#160;So far, the sale of cannabis for consumption purposes has been&#160;banned&#160;in&#160;</span><a href=”https://www.spiegel.de/thema/deutschland/” data-link-flag=”spon”><span>Germany</span></a><span>&#160;.&#160;The Greens and FDP have long been in favor of legal, regulated trade in cannabis.</span></blockquote>
It is significant when any nation moves towards cannabis legalization and away from prohibition. However, Germany is a particularly large domino to fall.

As of right now, only two countries have legalized cannabis for adult use – Uruguay and Canada. A number of countries are moving towards legalization, including Luxembourg which recently announced plans to legalize in 2022.

Switzerland allows low-THC cannabis products to be bought and sold, and court decisions in South Africa, Italy, and Mexico have created quasi-legalization.

Unless another country beats it to it, Germany would be the third country to comprehensively legalize cannabis for adult use, would be only the second G-7 nation to do so, and the first on the European continent to do so.

In the grand scheme of things, legalization in Germany is a much bigger deal compared to Uruguay and Canada because of the economics involved as well as the ripple effect that it will presumably create.

Germany has a population of roughly 83 million people, which dwarfs the populations of Canada (38 million) and Uruguay (3.5 million) combined. Whereas <a href=”https://worldpopulationreview.com/countries/countries-by-gdp”target=”_blank”>Germany</a> is home to the fourth-largest economy on earth, Canada’s economy is ranked 10th and Uruguay is ranked 80th.

Legalization in Uruguay was historic because it was the first country to legalize, and Canada was also historic in its own right for being the first G-7 nation to legalize. However, the global effect from Germany legalizing will almost certainly prove to be more significant.

Germany has long held a significant amount of political influence in Europe and beyond. It is also a major international hub for technological and industrial innovation.

If Germany beats all of its neighbors to adult-use legalization and becomes an adult-use oasis, the profit potential could be enormous. A recent study shed some light on what types of numbers can be expected. Below are excerpts about the study, via <a href=”https://www.reuters.com/world/europe/pot-gold-cannabis-could-bring-germany-5-billion-year-survey-2021-11-16/” target=”_blank” rel=”noopener”><em>Reuters</em></a>:
<blockquote>Legalising cannabis could bring Germany annual tax revenues and cost savings of about 4.7 billion euros ($5.34 billion) and create 27,000 new jobs, a survey said on Tuesday as politicians thrash out rules for the budding sector.

The survey by the Institute for Competition Economics (DICE) at the Heinrich Heine University in Duesseldorf, and commissioned by the German hemp association, found that legalising cannabis could lead to additional tax revenues of about 3.4 billion euros per year.

At the same time, it could bring cost savings in the police and judicial system of 1.3 billion euros per year while creating tens of thousands of jobs in the cannabis economy.</blockquote>
Legalization in Germany is still a work in progress, being that an actual law has not taken effect yet. With that being said, legalization does appear to be inevitable in Germany, and in the meantime, the eyes of the entire cannabis community will be locked on the European country.

How Much Public Revenue Would Cannabis Legalization Generate In Germany?

Germany is home to the largest legal medical cannabis market on the European continent. That is not surprising considering that Germany is home to the fourth-largest economy on the planet behind only the United States, China, and Japan.

Until recently, Germany imported more medical cannabis products than any other country and it was only recently that the country was passed on that front by Israel.

Part of that is due to the rise of domestic production in Germany and it’s also partly due to ongoing issues in Israel that have resulted in a spike in their medical cannabis imports.

It’s likely a safe bet that adult-use legalization in Germany would be huge. Germany is a massive domino and when it falls, the public policy repercussions will be felt throughout Europe and beyond.

A lingering question regarding adult-use legalization in Germany is how much money would such a public policy change yield for public coffers in Germany?

A recent study provides an answer to that very question. Excerpts about the study below, via Reuters:

Legalising cannabis could bring Germany annual tax revenues and cost savings of about 4.7 billion euros ($5.34 billion) and create 27,000 new jobs, a survey said on Tuesday as politicians thrash out rules for the budding sector.

The survey by the Institute for Competition Economics (DICE) at the Heinrich Heine University in Duesseldorf, and commissioned by the German hemp association, found that legalising cannabis could lead to additional tax revenues of about 3.4 billion euros per year.

At the same time, it could bring cost savings in the police and judicial system of 1.3 billion euros per year while creating tens of thousands of jobs in the cannabis economy.

Those numbers are very encouraging, and lead to the next logical question – when will Germany legalize cannabis for adult use? Germany legalized cannabis for medical use in 2017.

Earlier this month Bloomberg broke the news that a legalization coalition in Germany is gaining momentum and that the drafting of a strong legalization measure is nearing completion. Per Bloomberg:

Germany’s likely next ruling coalition is closing in on a deal to legalize cannabis for recreational use, the strongest signal yet that long-awaited growth of Europe’s marijuana market is gaining traction.

Negotiators for the Social Democrats, Greens and pro-business Free Democrats are hammering out the details, including conditions under which the sale and use of recreational cannabis would be allowed and regulated, according to people familiar with the talks, who asked not to be identified because the discussions are private.

At this point, it’s not a question of if Germany will legalize cannabis for adult use, it’s a question of when. Whether this latest measure passes or not, some type of legalization measure is going to pass sooner rather than later in Germany.

Luxembourg has already announced plans to legalize cannabis for adult use in 2022, and Italy also appears to be on a path to legalization in the near future. Countries like Switzerland and the Netherlands have adult-use pilot programs ramping up.

It’s very unlikely that lawmakers in Germany are going to sit by and see other countries reap the benefits of legalization. As we now know from the study cited in this article, there’s way too much money being wasted on prohibition and too much potential profit potential to keep prohibition in place.

The excitement in Germany is enormous, and support for cannabis reform and the emerging cannabis industry grows every day throughout Europe. Join us in Berlin in July 2022 at our flagship conference to get in on the action.

Our conference in Berlin is the largest cannabis industry B2B event on the European continent and the July 2022 conference is going to be the one biggest yet. To find out more info click here.

Is Cannabis Thailand’s Next Big Cash Crop?

You will be hardpressed to find a region on the planet that has historically been home to harsher cannabis laws than Southeast Asia. Of the seven countries that have imposed the death penalty for cannabis, over half of them are located in this region.

With that in mind, it was a very, very big deal when Thailand announced that it would become the first country in the region to legalize cannabis for medical use back in 2019.

When it was first announced, many cannabis advocates were understandably skeptical regarding how effective Thailand’s medical cannabis program would be given the history of the region.

However, Thailand is now home to one of the most progressive medical programs on earth, at least from a cultivation standpoint. Starting in March of this year, every household in Thailand can cultivate up to 6 plants.

To make it even better, families can form cultivation communities and sell their harvests to public hospitals and state facilities, and use their cannabis crops to make food and cosmetic products to sell.

In addition to helping suffering patients, the Thailand government sees cannabis as being a means for residents to boost their incomes, which was hammered home by recent comments from Thailand’s Health Minister. Per Pattaya Mail:

The Public Health Minister on Saturday visited a cannabis learning center in Bueng Kan province. He said in order to make cannabis production on par with the existing contracts, Thailand might have to have a central agency to collect the statistics of cannabis production and consumption.

He also cited that medicinal herb such as cannabis extracts and medication is becoming popular in Thailand, saying many shops and restaurants are incorporating cannabis in their menus.

In many ways, medical cannabis is being embraced by Thailand, and the country and its residents, especially suffering patients, will no doubt reap the rewards for decades to come as a result.

If/when medical cannabis proves to be an overwhelming success in Thailand hopefully it encourages other countries in the region to step up and get on the right side of history with their own cannabis laws.

Many areas in Southeast Asia are in desperate need of an economic boost. The cannabis industry can provide jobs, increased activity for local economies, and revenue for public coffers for all countries in Southeast Asia if given the chance.

Potential Legalization In Germany – The Hopeful Response From The Cannabis Industry

By Brautinvest.de Editorial Team

How do Germany’s industry leaders view a potential cannabis legalization? We asked around: In overall, the founders and CEOs of successful cannabis companies are hoping for growth opportunities, more control and thus better prevention than on the black market. They point to tax revenues and falling costs for the public budget. At the same time, they discuss the concrete design: Distribution through specialized stores or pharmacies? Cultivation in Germany or imports? And in view of the half-roll backward in Luxembourg – where only home cultivation is legalized – they also point out that nothing is yet set in stone. Critical voices are also being heard: Cannabis is more of a pharmaceutical product, not one for consumption. We were on the hunt for statements.

Growth market, tax revenues and relief for the state budget

Timo Bongartz, General Manager Fluence: “In Germany, we already have a strong ecosystem of companies that can successfully implement cannabis legalization in a structured way. Whether startup or corporation, whether industry, trade or capital provider, the market participants are ready. Now it’s a matter of sounding out politically and socially whether and how to go down the legalization path.”

Niklas Kouparanis, Co-Founder and CEO of Bloomwell Group: “Legalization is clearly on the horizon, even if cannabis will certainly not be legalized overnight in Germany. After all, it is one of the few issues on which all coalition partners are largely in agreement. The crux is the concrete, regulatory demanding, design – I strongly assume a future recreational sale through pharmacies. Product safety for the consumer must be the top priority here. Remind you, in the event of legalization in Germany, we are talking about the largest legal market in the world to date. From a business perspective, it would be negligent not to develop a strategy for this market. ‘The traffic light is green.'”

Benedikt Sons, co-founder and CEO of Cansativa: “Positive! A real growth driver for Germany as a business location: increasing tax revenues and numerous new jobs could boost the German economy. This is accompanied by the relief of the judiciary and authorities through the elimination of petty cannabis-related offenses – these not only swallow up time and paper, but also cost the state an enormous amount of money. From our point of view, the topic of cannabis will soon be socially acceptable, is gaining more and more support, and the task now is to create good conditions for a successful legal cannabis program with the right regulatory framework. Nevertheless, cannabis is not a product without concerns and it is important that dispensing takes place under certain conditions in order to reduce risks of abuse and, in particular, to protect vulnerable people or educate them about dangers.”

Lars Müller, CEO of Synbiotic: “The new government in Germany now gives us additional tailwind once again. The details are not yet known, but we expect a significant step forward in terms of legalization and commercialization.”

Ensuring individual and entrepreneurial freedom

Kai-Friedrich Niermann, lawyer and industry consultant: “The legalization of cannabis is overdue. A new cannabis policy is essential for the state and societal modernization that the new government is announcing. Individual personal freedom and corporate economic freedom of operation, embedded in a well-regulated framework of social responsibility, must be strengthened and failed government repressive policies replaced.”

Controlled dispensing instead of black market excesses

Finn Age Hänsel, founder Sanity Group: “Of course, a lot depends on the regulatory design of the dispensary, but in general I have been fighting for a liberalization of cannabis use for more than 20 years and I am happy to see something moving in politics now. Controlled dispensing and proper regulation solves more problems than continuing to accept the excesses of a growing black market. And by the way a cannabis tax also to plug Corona-related holes in the federal budget without burdening anyone more.”

Tobias Pietsch, owner: “Cannabis legalization is socially indispensable. We will be able to improve many of the problems that have arisen.”

Dr. Adrian Fischer, physician and natural scientist, co-founder and managing director of Demecan: “Instead of blanket legalization, smart deregulation is needed. This includes education and the protection of minors. In addition, there needs to be strict quality controls on cultivation and production, e.g. by the already existing German cannabis agency, which also controls medical cannabis, and a restriction of production to certified producers, ideally from Germany. Of course, cannabis as a stimulant is also a potential billion-dollar market that promises tax revenues and jobs. And in addition, law enforcement agencies and courts could be relieved. However, it is clear that legalization will also have to answer questions such as how to compensate for the actual risks that the healthcare system would face. Or where consumers should obtain cannabis. In licensed specialist stores or in pharmacies that have been dispensing cannabis as a medicine since 2017? One thing is certain: Pharmacists already have the relevant knowledge about the active ingredients, and can assess dose and purity. Because in the end, the goal must be to give citizens access to a controlled, high-quality product and protect them from dangerous goods from the black market.”

Regulatory challenge

Stephen Murphy, CEO & Co-Founder Prohibition Partners: “I do believe the legalisation will proceed in Germany, but both developing and executing the framework will take some time. This is a public health exercise and not an economic one by the government so it will require a more considered approach which is to say that the supply chain won’t vary too much from current expected standards. I’d place a (small) bet on Germany going legal before the US!

Coordination at the European level

Daniel Kruse, entrepreneur and EIHA President: “EIHA welcomes cannabis legalization in Germany, which will provide another boost to the European hemp industry and help end decades of hemp stigma. However, we urge the German government to closely coordinate the new legal framework with its European partners and to advocate for a harmonized commercial hemp and cannabis strategy across Europe. In addition, legalization must be designed to be as socially responsible and fair as possible, including in terms of youth protection, prevention and participation in road traffic.”

More than home cultivation – skepticism remains

Alfredo Pascual, Vice-President of Investment Analysis at Seed Innovations: “It’s still too early to know with certainty when and how adult-use cannabis will be legalized in Germany.

In neighboring Luxembourg, the government promised full-blown legalization in its 2018 Koalitionsvertrag, yet three years later it looks like they will settle on only allowing to grow a few plants at home for personal use, which is a step in the right direction but far from ideal.

I hope that if German policymakers in the new government agree that cannabis should be legalized, that they will have the courage to go beyond what their peers in Luxembourg did.”

Cannabis is a pharmaceutical product

Linus M. Weber – Founder & M.D.: “Cannabis is a legal pharmaceutical product and we need to enforce that more broadly in Germany so that more patients can be treated. For this, legalization as a stimulant is not conducive, but pushes potential prescribers and patients back again. In my opinion, the only right way is to continue to offer cannabis only pharmaceutically. However, whether it must continue to be prescribed or whether products with low THC content can also be made available in pharmacies without a prescription should be examined in detail.”

This article was first published on krautinvest.de in German: https://krautinvest.de/potenzielle-legalisierung-das-hoffnungsvolle-echo-aus-der-cannabis-industrie/

JPMorgan: No Trading Certain U.S. Cannabis Stocks

Cannabis stocks are a popular and easy way to invest in the emerging cannabis industry. As any seasoned investor will point out, cannabis stocks are young compared to stock offerings from more established industries, and the landscape in which those companies operate is always evolving. That creates risk.

To make matters more complicated in the United States, not all cannabis stocks are listed on major stock exchanges. Cannabis, of course, remains illegal at the federal level in the U.S. and that creates even greater risks for certain cannabis companies.

All of that risk, combined with the fallout from the collapse of a private fund, has led JPMorgan to cease all trading of certain U.S.-based cannabis stocks. Per excerpts from an article first published by Reuters:

JPMorgan Chase & Co (JPM.N) has told prime brokerage clients it will no longer let them buy certain U.S. cannabis-related securities beginning Nov. 8, according to a letter seen by Reuters.

“J.P. Morgan (JPMS) has introduced a framework that is designed to comply with U.S. money laundering laws and regulations by restricting certain activities in the securities of U.S. Marijuana Related Businesses,” the bank wrote to clients.

As of Nov. 8, the bank will not allow new purchases or short positions in the related businesses, but clients with existing positions will be allowed to liquidate them, it said.

Cannabis stocks have taken a pounding this year, especially stocks for United States companies. JPMorgan’s announcement could, unfortunately, add to the trend, at least in the immediate future.

Cannabis companies that ‘touch the plant’ and are not listed on the Nasdaq, the New York Stock Exchange, or the Toronto Stock Exchange are subject to JPMorgan’s new policy.

Feiras E Congressos Alavancam A Indústria E Fomentam A Cultura Canábica

This article was originally published by Poder360 and republished here with special permission from the author

By Anita Krepp

Cursos e workshops extraoficiais oferecidos por empreendedores autônomos que viajam para participar do evento principal criam agenda paralela com aulas de cultivo, culinária e extração

Se, mesmo depois de tantos anos, o mistério sobre quem nasceu primeiro, o ovo ou a galinha, ainda não foi definitivamente solucionado, questões de mesmo cunho filosófico, como quem surgiu primeiro, a cultura ou a indústria da cannabis, também estão longe de serem elucidadas. No entanto, uma coisa é certa, a indústria só encontra terreno fértil para crescer e prosperar em uma cultura vibrante e ativa em torno da planta, duas características que as feiras e congressos canábicos cultivam há quase duas décadas, e vem se fortalecendo significativamente de dois anos para cá.

Talvez seja por isso que você anda recebendo cada vez mais convites para participar desse tipo de evento. A indústria já percebeu que o caminho para gerar mais lucro é apostar na formação e no networking de seus atores e consumidores, especialmente por se tratar de um nicho que carece de um rebranding para afastar os antigos preconceitos e de muita educação sobre o que ele de fato é. E apesar do enorme desafio imposto aos realizadores destes eventos durante o confinamento na esteira da pandemia, a indústria seguiu se reunindo e debatendo, ainda que nos últimos meses apenas virtualmente.

Com a volta gradual à normalidade, os eventos presenciais devem reunir um público ainda maior do que em 2019, aposta Alex Rogers, fundador da International Cannabis Business Conference, uma rede internacional de conferências B2B, especialmente porque a maioria das pessoas passou a maior parte do tempo trancafiada em casa e não vê a hora de encontrar seus pares. Mesmo todas as facilidades de um encontro por vídeo não substituem o “cara a cara” na hora de fechar um contrato milionário — somente na International Cannabis Business Conference de 2019, os negócios fechados superam os 100 milhões de dólares. Por isso mesmo, Rogers prepara um espaço de 65 mil m2, o maior até então, para receber mais de 5 mil pessoas na próxima edição, que acontecerá em Berlim, em julho de 2022.

Em meio a centenas de eventos espalhados pelo mundo, alguns de destacam ao catalisar investidores, empresários, produtores e também o público em geral. Um deles, quiçá o de maior expressividade, ocorre na América Latina. O Expocannabis Uruguai acontece no início de dezembro e vem ganhando relevância por se tratar de um país pioneiro na legalização da substância. Isso possibilita, entre outras coisas, o contato direto do público com plantas e flores de cannabis, inclusive com altas concentrações de THC, algo que não é oferecido em nenhum outro lugar, devido às restrições regulamentares ao canabinóide psicoativo.

“Sentir o cheiro da erva e poder sair para uma área reservada dentro do evento para acender um ´baseado´é o tipo de experiência única da Expo Uruguai”, garante Meche Ponce de León, idealizadora e produtora da feira que, desde a primeira edição, em 2014, recebe centenas de brasileiros, que representam o maior público estrageiro. Mas, afinal, o que é que nós vamos buscar na grama do vizinho — que, neste caso, diga-se, é sim infinitamente mais verde? A resposta é simples: experimentar, nem que seja por alguns dias, o gostinho de viver em um ambiente legalizado. Aliás, legalizado e inspirador. Ao passear por vários estandes de empresas de fertilizantes, parafernalhas para autocultivo, óleos medicinais e até banco de sementes, parece que um mundo novo vai surgindo, repleto de possibilidades de negócios que impactariam diretamente a economia não só do país, mas também de gente criativa, ávida por empreender num nicho tão promissor.

Além disso, feiras como essas contam com espaços de socialização, com música e comida, além de um auditório para as conferências e bate-papos a respeito das novidades do mercado, o que envolve saúde, indústria e uso recreativo da erva. Discussões, por exemplo, sobre os efeitos de uma enorme variedade de cepas (espécies de flores de cannabis) que você provavelmente nem sabia que existiam são comuns e muito disputadas.

Legalização não é nada sem cultura

É claro que feiras e congressos são importantes em qualquer outro setor da indústria, mas, quando se trata do incipiente ecossistema da cannabis, são alçadas a um protagonismo único, assumindo um papel fundamental em articulações que envolvem a pressão sobre autoridades, a viabilização de movimentos sociais e a luta dos pacientes, pautas fundamentais para a estruturação e o desenvolvimento do mercado. Estes espaços de promoção do acesso à informação e conhecimento se tornaram cruciais para que potenciais consumidores saibam aquilo que têm à sua disposição, o que naturalmente cria novas demandas de venda.

Somos todos ainda ignorantes — em menor ou maior grau — nos assuntos relacionados à cannabis. Há pouco tempo atrás, até o maconheiro mais raiz pensava que os fungos do prensado paraguaio, o típico “tijolinho de maconha”, modalidade mais difundida no varejo do uso recreativo e de qualidade algo duvidosa, potencializavam os efeitos da erva, quando, na verdade, causam danos ao pulmão. Tamanho equívoco se deve a uma cultura proibicionista, onde, em muitos lugares, apenas tocar no tema é tabu, o que acaba por sufocar a informação e, por conseguinte, a liberdade e as melhores tomadas de decisão. Ignorância, sim, é muito prejudicial à saúde.

Mesmo onde a indústria está legalizada, como na Colômbia, em que gigantescas estufas anteriormente voltadas ao cultivo de rosas agora são destinadas à cannabis, a falta de uma cultura canábica consolidada impossibilita o surgimento de negócios como distribuidores, growshops e bancos de semente, fazendo, assim, com que o debate social seja uma coisa meio morna, e o país seja um eterno predestinado à exportação de insumos. É o resultado que se obtém ao desprezar o potencial crescimento econômico promovido pela cultura da cannabis.

Cultura essa que, aliás, pode mudar de rumo e apontar novos caminhos. Raúl del Pino, da Spannabis, maior evento do ramo na Espanha e um dos mais importantes do mundo desde 2002, sentiu o cheiro de oportunidade no mercado medicinal da planta e não desperdiçou a oportunidade. Ele já prepara o lançamento da CBD Business Fair, específica para produtos de CBD e cânhamo, para outubro do ano que vem.

É pena que, no Brasil, a pobre regulamentação vigente, ainda restrita aos setores abastados da sociedade, siga desprezando os potenciais industriais, econômicos e culturais da erva. Contudo, nem tudo são lástimas. Há um burburinho cultural crescente, estimulado por eventos como o Cannabis Thinking, que promove discussões pertinentes sobre o próprio ecossistema e o networking entre os players da indústria no país. Tudo, porém, sem o cheiro da erva. Aos que ficarem com gostinho de quero mais, resta dar um pulinho no país vizinho.

Agenda paralela dos eventos extraoficiais

O número de turistas brasileiros que cruzam a fronteira para visitar a expo no Uruguai cresce a cada ano, com gente ávida por, digamos, visitar um “salão do automóvel”… com automóvel. Grande parte desse público se une a iniciativas como a Rádio Hemp, que já tem dois ônibus cheios com saída marcada para dezembro, e aos pacotes de viagens oferecidos por agências de turismo canábico, como a MiCasa420. No meio dos entusiastas que pegarão a estrada, há também alguns profissionais e empreendedores canábicos. Eles aproveitam a concentração em um só lugar desse público selecionado para também comercializar seus produtos e serviços. Que sorte, não, poder trabalhar no seu ofício sem correr o risco de ser preso por isso?

Talvez, o que melhor ilustre a formação de uma cultura canábica aconteça justamente para além dos muros do evento oficial. Do lado de dentro, o público está buscando algo específico, tem uma agenda de visitação pré-definida, digamos, estando menos abertos, portanto, ao improviso. Mas, do lado de fora, acontece a mágica. Atividades mais dinâmicas, onde as pessoas se conectam de outra maneira. Todos os dias do evento principal e também nos dias prévios ou seguintes a ele, há uma agenda intensa de atividades. Caio Cézar, do canal Cozinha4e20, sonha em poder fazer uma fornada de brownie e anunciar que vai estar em alguma praça brasileira vendendo seu produto sem, necessariamente, arrumar problemas por isso. Mas, enquanto essa possibilidade não se realiza, Cézar viaja ao Uruguai, aluga uma casa e monta um menu com infusão de cannabis para receber os convidados pagantes deste jantar.

Festas, noites temáticas de drinks ou brownies com cannabis, rodízios de pizza, e tudo isso regado a muito papo que metalinguisticamente discute a própria cultura canábica gerada naquele lugar. No dia seguinte, city tour canábico e vários cursos e workshops de culinária, extração e cultivo da terra. Se, antes, os jovens trocavam figurinhas sobre qual boca de fumo era menos perigosa ou onde o fumo estava mais em conta, hoje começam a falar sobre cultivo, pH da água, substratos e técnicas de germinação. Pelo visto, a difusão da cultura canábica não só fomenta a economia, como também traz uma nova perspectiva para a garotada. Ao que tudo indica, é só questão de tempo para o famigerado prensado paraguaio virar peça de museu.